SOLENO THERAPEUTICS INC
COM · CUSIP 834203101
1
institutional holders
510.6k
shares reported held*
$1.5mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.94.
Holders, Q4 2019
| Manager | Shares | Change |
|---|---|---|
| Birchview Capital, LP 1.09% of their portfolio | 510.6k $1.5m | — |